BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3729742)

  • 1. Parkinson's disease in patients with Alzheimer's disease.
    Leverenz J; Sumi SM
    Arch Neurol; 1986 Jul; 43(7):662-4. PubMed ID: 3729742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 68-year-old woman with dementia and parkinsonism].
    Yokoyama K; Ikebe S; Komatsuzaki Y; Takanashi M; Mori H; Mochizuki H; Mizuno Y
    No To Shinkei; 2002 Feb; 54(2):175-84. PubMed ID: 11889767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An autopsy case of Alzheimer's disease associated with Parkinson's disease, compared to 2 autopsy cases of diffuse Lewy body disease].
    Hirunagi N; Hashizume Y; Hamaguchi Y; Katsui Y; Kashiwagi H
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):214-9. PubMed ID: 2384995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis.
    Hedera P; Lerner AJ; Castellani R; Friedland RP
    J Neurol Sci; 1995 Feb; 128(2):219-24. PubMed ID: 7738598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
    Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
    Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):972-5. PubMed ID: 1800669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM; Basgall EJ; Zamrini E; Hill WD
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.
    Ditter SM; Mirra SS
    Neurology; 1987 May; 37(5):754-60. PubMed ID: 3033544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    Neuropathol Appl Neurobiol; 1989; 15(1):27-44. PubMed ID: 2542825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
    Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
    Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
    Love S; Wilcock GK; Matthews SM
    Acta Neuropathol; 1996; 91(4):432-6. PubMed ID: 8928622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm Suppl; 1996; 48():1-6. PubMed ID: 8988457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.